Finance
Finance
Home214150 • KOSDAQ
Classys Inc
₩52,300.00
Apr 2, 6:37:21 PM GMT+9 · KRW · KOSDAQ · Disclaimer
Stock
Previous close
₩54,600.00
Day range
₩51,600.00 - ₩55,200.00
Year range
₩45,450.00 - ₩77,600.00
Market cap
3.41T KRW
Avg Volume
573.45K
P/E ratio
26.08
Dividend yield
1.91%
Primary exchange
KOSDAQ
Market news
Financials
Income Statement
Revenue
Net income
(KRW)Dec 2025Y/Y change
Revenue
93.43B25.57%
Operating expense
20.83B-0.88%
Net income
42.64B48.49%
Net profit margin
45.6418.27%
Earnings per share
EBITDA
54.92B39.15%
Effective tax rate
21.47%
Total assets
Total liabilities
(KRW)Dec 2025Y/Y change
Cash and short-term investments
207.56B31.33%
Total assets
704.65B15.82%
Total liabilities
152.98B-1.77%
Total equity
551.67B
Shares outstanding
65.15M
Price to book
6.43
Return on assets
18.83%
Return on capital
20.58%
Net change in cash
(KRW)Dec 2025Y/Y change
Net income
42.64B48.49%
Cash from operations
91.49B130.83%
Cash from investing
-79.53B-308.65%
Cash from financing
-8.91B-612.48%
Net change in cash
2.37B-87.79%
Free cash flow
60.67B0.85%
About
Classys Inc. is a South Korean medical device company headquartered in Seoul, South Korea. It was founded in 2007 by dermatologist Jung Sung-jae and specializes in non-invasive skin care and aesthetic treatment technologies. As of 2025, Classys exports its devices to over 60 countries. Wikipedia
Founded
2007
Employees
394
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu